Company profile for Taiho Oncology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Taiho Oncology is a different kind of pharmaceutical company. We have deep roots and unmatched corporate agility that enable us to fulfill our purpose – making a better world for cancer patients and the people who care for them. Our corporate philosophy is “We strive to improve human health & contribute to a society enriched by smiles.”For almost two decades, Taiho Oncology has served as a world-class clinical organizati...
Taiho Oncology is a different kind of pharmaceutical company. We have deep roots and unmatched corporate agility that enable us to fulfill our purpose – making a better world for cancer patients and the people who care for them. Our corporate philosophy is “We strive to improve human health & contribute to a society enriched by smiles.”For almost two decades, Taiho Oncology has served as a world-class clinical organization, where people are at the center of everything we do. We work urgently to discover and develop innovative cancer treatments that address today’s unmet patient needs and apply the science behind them in novel ways.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
101 Carnegie Center, Suite 101 Princeton, New Jersey 08540
Telephone
Telephone
609-750-5300
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-12-03/taiho-oncology-europe-announces-the-launch-of-lytgobi-futibatinib-in-the-united-kingdom-for-elig

PHARMIWEB
03 Dec 2025

https://www.prnewswire.com/news-releases/taiho-oncology-taiho-pharmaceutical-and-cullinan-therapeutics-initiate-rolling-submission-of-new-drug-application-to-us-food-and-drug-administration-for-zipalertinib-for-treatment-of-locally-advanced-or-metastatic-non-small-cel-302621302.html

PR NEWSWIRE
20 Nov 2025

https://www.prnewswire.com/news-releases/taiho-oncology-announces-14-presentations-including-six-oral-presentations-at-the-67th-american-society-of-hematology-annual-meeting-and-exposition-302613890.html

PR NEWSWIRE
13 Nov 2025

https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-present-data-on-zipalertinib-in-patients-with-nsclc-with-egfr-mutations-and-active-brain-metastases-at-the-esmo-congress-2025-302581514.html

PR NEWSWIRE
13 Oct 2025

https://www.biospace.com/drug-development/cullinan-taihos-nsclc-hopeful-shows-strong-activity-clearing-road-to-fda

BIOSPACE
10 Sep 2025

https://www.prnewswire.com/news-releases/taiho-oncology-and-cullinan-therapeutics-present-data-on-zipalertinib-at-the-iaslc-2025-world-conference-on-lung-cancer-302549926.html

PR NEWSWIRE
09 Sep 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty